Skip to content
Astek Diagnostics logo

Astek Diagnostics

Astek Diagnostics is a YC Summer 2021 (S21) company. Based in Baltimore, MD, USA. Team of 5.

  • Microfluidics
  • Medical Devices

About Astek Diagnostics

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Astek Diagnostics builds a rapid clinical diagnostics platform, JIDDU, that confirms urinary tract infections and indicates antibiotic sensitivity within one hour by detecting bacterial oxygen consumption. Physicians currently wait days for standard culture results and often prescribe antibiotics by guesswork; JIDDU replaces that delay with point-of-care guidance. The platform targets a particularly high-stakes gap given that UTIs are a leading driver of sepsis and disproportionately affect women.

Go-to-market

The platform is aimed at clinical settings where physicians, particularly those managing infection-prone patients, need rapid point-of-care diagnostic support to guide antibiotic prescribing decisions.

From the Y Combinator listing

How Astek Diagnostics describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

One-hour antibiotic sensitivity testing

Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
Baltimore, MD, USA
Team size
5
Status
Active
Stage
Early

Founders (1)

  • Mustafa Al-Adhami
    Founder

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works